MMM — Medicare/Medicaid
H.R. 2586, Reentry Act of 2025, policies related to reimbursement of substance use disorder treatment.
Lobbyists: KARINA LYNCH; RACHEL PORTMAN; mrs NICOLE MARIE RUZINSKI BERTSCH
5f927cc5-0f56-4ec5-b7be-e0b7fd73f50e1T — 1st Quarter - TerminationLaw firm.
Pharmaceutical company
MMM — Medicare/MedicaidH.R. 2586, Reentry Act of 2025, policies related to reimbursement of substance use disorder treatment.
Lobbyists: KARINA LYNCH; RACHEL PORTMAN; mrs NICOLE MARIE RUZINSKI BERTSCH
HCR — Health IssuesGeneral education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels.Issues related to access to addiction treatments, including telehealth.
Lobbyists: KARINA LYNCH; RACHEL PORTMAN; mrs NICOLE MARIE RUZINSKI BERTSCH
Government entities lobbied: SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.
Estimated value: $180/mo per user — but we made it free.
Want to partner? Contact us.